FDA Brief

Warning letters Drugs

FDA warning letter to

Baxter Healthcare Corporation

High riskIssued Jul 25, 2023Posted Aug 1, 2023Center for Drug Evaluation and Research | CDER

FDA warned Baxter over CGMP violations at its India plant, including inadequate endotoxin and visual inspection investigations for sterile injectables.

What happened

FDA inspected the Baxter Pharmaceuticals India Pvt. Ltd. facility from January 19 to January 27, 2023, and reviewed the company’s February 17, 2023 response. The letter cites CGMP violations including inadequate investigations into invalidated endotoxin tests and failures of an automated visual inspection machine, a clean tank with product residue, and equipment design issues near open vials. FDA said the violations repeat problems and that Baxter failed to correct repeat violations.

What FDA found

  1. Baxter did not thoroughly investigate unexplained failures, including invalidated endotoxin tests and automated visual inspection failures.

    21 CFR 211.192
  2. Baxter did not establish or follow adequate written cleaning and maintenance procedures; FDA found white spots identified as previously processed product in a tank documented as clean.

    21 CFR 211.67(b)
  3. Baxter’s production and process controls for visual inspection were inadequate, including manual inspections shorter than its procedures required and defect kits missing harder-to-detect particles.

    21 CFR 211.100(a) and (b)
  4. Baxter used manufacturing equipment that was damaged or poorly designed, including open vials exposed to worn bolt threading and employees ducking under a conveyor near open vials.

    21 CFR 211.63
  5. FDA found the quality unit was not enabled to exercise proper authority or did not sufficiently implement its responsibilities.

What FDA wants

FDA tells Baxter to correct violations promptly and respond in writing within 15 working days with corrective actions and schedules. FDA also requests several independent assessments and remediation plans and asks the company to email within five days to schedule a regulatory meeting.

Who should pay attention

  • drugmakers that buy sterile injectables from this site
  • contract manufacturers and suppliers with shared equipment
  • quality teams managing visual inspection and endotoxin testing

This is a summary. Read the original letter on fda.gov.

Baxter Healthcare Corporation's FDA history

Recalls in the last 12 months

Nov 11 Class II Baxter Healthcare Corporation
Device
TruSystem 7500 Hybrid Plus (FC), Fixed-Installation Operating Table Column, Model/Catalog Number: 1854087
There is an issue with the main lift mechanism. The main lift may unexpectedly drop from its set position to its lowest position during use. In these cases, the tabletop could not be raised again after the drop occurred. The issue has been associated with unexpected wear of the main lift assembly, also known as the telescopic spindle. An uncontrolled drop of the surgical table may result in an abrupt patient displacement during surgery. Serious or critical adverse health consequences may occur, including traumatic injury, airway compromise, and surgical procedure complications, among others. Baxter has received three complaints related to this issue, with no reported patient injury.
Nov 11 Class II Baxter Healthcare Corporation
Device
Operating Table TruSystem 7000 U (dV), Model/Catalog Number: 1723633
There is an issue with the main lift mechanism. The main lift may unexpectedly drop from its set position to its lowest position during use. In these cases, the tabletop could not be raised again after the drop occurred. The issue has been associated with unexpected wear of the main lift assembly, also known as the telescopic spindle. An uncontrolled drop of the surgical table may result in an abrupt patient displacement during surgery. Serious or critical adverse health consequences may occur, including traumatic injury, airway compromise, and surgical procedure complications, among others. Baxter has received three complaints related to this issue, with no reported patient injury.
Nov 11 Class II Baxter Healthcare Corporation
Device
Operating table column TS7500 MOBIUS, Hybrid operating table column, Model/Catalog Number: 1704695
There is an issue with the main lift mechanism. The main lift may unexpectedly drop from its set position to its lowest position during use. In these cases, the tabletop could not be raised again after the drop occurred. The issue has been associated with unexpected wear of the main lift assembly, also known as the telescopic spindle. An uncontrolled drop of the surgical table may result in an abrupt patient displacement during surgery. Serious or critical adverse health consequences may occur, including traumatic injury, airway compromise, and surgical procedure complications, among others. Baxter has received three complaints related to this issue, with no reported patient injury.
Nov 11 Class II Baxter Healthcare Corporation
Device
TruSystem 7000 U Operating Table (dV), Product Code 1723633
The main lift may unexpectedly drop from its set position to its lowest position during use. The tabletop may not be able to be raised again after the drop occurs. An uncontrolled drop of the surgical table may result in an abrupt patient displacement during surgery. Serious or critical adverse health consequences may occur, including traumatic injury, airway compromise, and surgical procedure complications, among others.
Nov 11 Class II Baxter Healthcare Corporation
Device
Operating Table TruSystem 7000 U, Surgical table, universal, Model/Catalog Number: 1604788
There is an issue with the main lift mechanism. The main lift may unexpectedly drop from its set position to its lowest position during use. In these cases, the tabletop could not be raised again after the drop occurred. The issue has been associated with unexpected wear of the main lift assembly, also known as the telescopic spindle. An uncontrolled drop of the surgical table may result in an abrupt patient displacement during surgery. Serious or critical adverse health consequences may occur, including traumatic injury, airway compromise, and surgical procedure complications, among others. Baxter has received three complaints related to this issue, with no reported patient injury.
Nov 11 Class II Baxter Healthcare Corporation
Device
Mobile column TruSystem 7500 U, Product Code 1730720
The main lift may unexpectedly drop from its set position to its lowest position during use. The tabletop may not be able to be raised again after the drop occurs. An uncontrolled drop of the surgical table may result in an abrupt patient displacement during surgery. Serious or critical adverse health consequences may occur, including traumatic injury, airway compromise, and surgical procedure complications, among others.
Nov 11 Class II Baxter Healthcare Corporation
Device
TruSystem 7500 surgical table, Model/Catalog Number: 4091000
There is an issue with the main lift mechanism. The main lift may unexpectedly drop from its set position to its lowest position during use. In these cases, the tabletop could not be raised again after the drop occurred. The issue has been associated with unexpected wear of the main lift assembly, also known as the telescopic spindle. An uncontrolled drop of the surgical table may result in an abrupt patient displacement during surgery. Serious or critical adverse health consequences may occur, including traumatic injury, airway compromise, and surgical procedure complications, among others. Baxter has received three complaints related to this issue, with no reported patient injury.
Oct 21 Class II Baxter Healthcare Corporation
Device
Likorall Overhead Lifts Product Code: 3121001 Product Description: LIKORALL 200 Product Code: 3122005 Product Description: LIKORALL 242 ES, NATURAL Product Code: 3122005NA Product Description: LIKORALL 242 ES…
Potential issue involving motor shaft breakage combined with reduced performance of the Single Fault Safety (SFS) system may lead to instances where the lift strap lowers more quickly than expected during use. Patients are at some risk for injury if a significant fall/drop were to occur due to this issue.
Sep 30 Class II Baxter Healthcare Corporation
Device
PRO+ 40" MRS SURFACE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system of intake and output valves to provide weight-based pressure redistribution whenever a patient moves or is repositioned…
There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the approved product or product specifications and may lead to incorrect product identification or selection, potentially resulting in use with an incompatible bed frame.
Sep 30 Class II Baxter Healthcare Corporation
Device
Brand Name: VOLARA System Product Name: VOLARA, HC, NA A Model/Catalog Number: M08594A Software Version: N/A Product Description: VOLARA, HOMECARE, NORTH AMERICA Component: No
Contamination within the release test equipment flow path could have affected the accuracy of the nebulizer flow rate. Affected devices returned to firm and testing confirmed devices meet specifications.
Sep 30 Class II Baxter Healthcare Corporation
Device
PRO+ MRS SURFACE FOR VERSACARE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system of intake and output valves to provide weight-based pressure redistribution whenever a patient moves or is re…
There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the approved product or product specifications and may lead to incorrect product identification or selection, potentially resulting in use with an incompatible bed frame.
Sep 30 Class II Baxter Healthcare Corporation
Device
PRO+ 36" MRS SURFACE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system of intake and output valves to provide weight-based pressure redistribution whenever a patient moves or is repositioned…
There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the approved product or product specifications and may lead to incorrect product identification or selection, potentially resulting in use with an incompatible bed frame.
Sep 16 Class I Baxter Healthcare Corporation
Drug
Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Sep 9 Class II Baxter Healthcare Corporation
Device
Baxter Novum IQ Syringe Pump, Model Number 40800BAXUS
A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a syringe reaches empty and is replaced while a Volume To Be Infused (VTBI) remains.
Sep 9 Class II Baxter Healthcare Corporation
Device
Baxter Novum IQ Syringe Pump, Loaner, Model Number 40800BAXUSL
A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a syringe reaches empty and is replaced while a Volume To Be Infused (VTBI) remains.
Sep 9 Class II Baxter Healthcare Corporation
Drug
Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3814-50.
CGMP Deviations
Sep 9 Class II Baxter Healthcare Corporation
Drug
Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60012 USA, NDC 0338-9640-12.
CGMP Deviations
Sep 9 Class II Baxter Healthcare Corporation
Drug
Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC …
CGMP Deviations
Sep 9 Class II Baxter Healthcare Corporation
Drug
CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA…
CGMP Deviations
Sep 9 Class I Baxter Healthcare Corporation
Drug
0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made in USA, NDC 0338-0049-03
Presence of particulate matter: Particulates identified as fiberglass

Full company page

Similar letters to other companies

  1. Natural Essentials, Inc.

    FDA warns Natural Essentials over OTC drug manufacturing violations, including inadequate failing test result investigations and missing component identity tests.

    High risk
  2. Shenzhen Benliju Biotech Co., Ltd.

    FDA: Shenzhen Benliju Biotech released OTC drugs labeled sterile without sterility testing or process validation.

    High risk
  3. LGM Pharma Solutions, LLC

    FDA warned LGM Pharma Solutions over manufacturing-quality failures in failing-result investigations and process validation for tablets, including a recalled product.

    High risk
  4. Penn Herb Company, Ltd.

    FDA warned Penn Herb Company over CGMP violations and an undeclared tree-nut allergen in three dietary supplements.

    High risk